KAYON Campbell, otherwise called ‘Treasure’, who was wanted by police for breaching his bail conditions, is now back in police custody.

Police said that Campbell had been offered bail in a case of conspiracy to murder and other offences, but breached his bail conditions. Accompanied by his attorneys, Campbell turned himself in to the officer in charge of his case at the Supreme Court about 11:00 am today,

COULD Supreme Promotions, organisers of Sting — the world’s largest one-night reggae festival — be making moves to bring in embattled deejay Buju Banton for the December 26 event?

News of this development has been swirling in entertainment circles all week and was given an even further push following Wednesday’s decision by US judge James Moody to grant the artiste the opportunity to perform at a concert in Miami on January 16.

When contacted, director of Supreme Promotions, DiMario McDowell told Splash: “My lips are sealed on that matter. I have absolutely no comment.”

The word on the street is that high-level channels are being pursued by Supreme Promotions in order to get Buju, who is currently facing criminal charges in Florida, to perform at the event.

McDowell, however, added that the full line-up of the 27th annual staging of show, scheduled for the Jamworld Complex in Portmore, St Catherine, would be known tonight (Friday) at the launch of the Sting promotional poster at Blaze Nightclub in Portmore.

And following Wednesday’s decision by the judge comes more good news for the artiste born Mark Myrie.

His most recent album, Before The Dawn, has been nominated for a Grammy award in the category Best Reggae Album. This is Buju Banton’s fifth Grammy nomination.

Before The Dawn was recorded mostly at his Gargamel Music Studio in Kingston. Released in September to critical acclaim, Before The Dawn debuted at No 2 on Billboard’s Reggae Albums chart and No 26 on the mag’s Heatseekers chart. Currently the album is perched at No 1 on both the South Florida and the New York Top 20 Reggae Albums charts, No 1 on Richie B’s Jamaica Music Countdown and No 4 on CMJ’s World Music chart.

The album’s unofficial anthem, Innocent, is said to strike a highly personal chord considering the artiste’s legal battles.

Banton previously received Grammy nominations for his albums Rasta Got Soul (2009), Too Bad (2007), Friends For Life (2004) and Inna Heights (1999).

The veteran-reggae artiste, who had been incarcerated at Pinellas County Jail for 11 months, has not performed live in over a year.

GLOBAL athletics brand Puma listed Jamaican sprinter Usain Bolt as its key brand-asset amidst a 16 per cent rise in sales to 784 million euros over the third-quarter.

The German-based brand described the new three-year contract with Bolt as the most important event in its quarter behind its financials. It even ranked it above a multi-million full take-over of a joint-venture in China and Hong Kong and also irregularities discovered at a second joint-venture in Greece, according to its latest financials.

GLOBAL athletics brand Puma listed Jamaican sprinter Usain Bolt as its key brand-asset amidst a 16 per cent rise in sales to 784 million euros over the third-quarter. The German-based brand described the new three-year contract with Bolt as the most important event in its quarter behind its financials. It even ranked it above a multi-million full take-over of a joint-venture in China and Hong Kong and also irregularities discovered at a second joint-venture in Greece, according to its latest financials. Usain Bolt

“Usain Bolt remains a long-term brand asset for Puma,” stated the first page of the financials which incidentally had a life-sized photo of Bolt on its cover.

Puma’s intangible fixed-assets (with a non-defined useful life) had an opening balance of €70 million on January 2009 and closing balance of €26 million at December 2009.

The contract signed for an undisclosed sum in August represents, according to Puma, the largest sponsorship contract by a track and field athlete to date. It follows the estimated eight-figure Nike contract received by US sprinter Carl Lewis. Bolt, the two-time world record holder and triple World and Olympic champion entered the Puma contract in 2003 which runs until 2013.

Over the third-quarter, Puma’s net profit jumped 14 per cent to €77 million; its gross profit margin remained at 50 per cent; operating result before special items improved 5.3 per cent to €113 million; whilst earning per share rose from €4.50 to €5.16.

It isn’t the first time that Puma has lauded the value of Bolt to its investors. In its 2009 annual report Puma indicated that the performance of “Bolt at the World Athletics Championships in Berlin, where he broke the 100m and 200m world records, proved to be a particular highlight for the Puma brand”.

Puma views its brand image as key to its marketing of apparel, clothing and footwear.

“The brand image is essential since it can influence consumer behaviour not only to the advantage, but also to the disadvantage, of the brand,” it stated in its financials.

JAMAICAN scientist Dr Henry Lowe last night threw a lifeline to men worldwide when he announced that he had developed a formula that can reduce and eliminate prostate cancer, the number one cause of cancer deaths among males.

“I am pleased to announce that we have reached the final stages in the development of the Alpha Prostate Formula, which will be on the market in the next three months under the Eden Gardens brand,” Dr Lowe told guests at the launch of Bio-Tech R&D Institute at the Terra Nova Hotel in Kingston.

Lowe, executive chairman of Environmental Health Foundation which is based at his Eden Gardens complex in Kingston, explained that the formula will be locally produced, first as a nutraceutical.

“The drug takes time and millions of US dollars to develop, so that is why we’re making it available in its semi-purified form,” Dr Lowe told the “Vibez” in an interview outside of the launch.

Dr Joseph Bryant from the University of Maryland Medical School and a shareholder in Bio-Tech R&D Institute, agreed. “We have to go by the rules and the regulations as to how fast we can get it out there, but the nutraceutical thing now allows us to get it out much faster,” he told the “Vibez’.

“We cannot overemphasise the point of what this means for the country, and I hope that the younger generation will carry it on,” Dr Bryant added.

Lowe’s cancer research work attracted world attention when he announced that he had found properties in the Jamaican ball moss that had the potential to fight cancer.

Yesterday, he said that the formula is derived from the main ingredient in the ball moss and has been shown to have major prostate anti-cancer activity.

Jamaica has one of the highest prostate cancer rates in the world with approximately 150 men diagnosed each year. Medical experts believe that a large percentage of affected men are undiagnosed.

Yesterday, Lowe, who won the Observer Business Leader Award for 2006, noted that in addition to Jamaica, numerous cases of prostate cancer have been reported among black Americans and Africans.

“The market for that is tremendous and there are only two other products as nutraceuticals for this,” he said. “This is going in there, brand Jamaica, and if we get the right thrust and the right support we have hundreds of millions of US dollars which can come to Jamaica.”

Yesterday, in his prepared remarks, Lowe said that as a first step in the development of the nutraceutical industry, Bio-Tech R&D Institute has already secured capital of $25 million, which will contribute to the overall development of the institute in the next 24 months. Further capitalization of $25 million is expected within the next 48 months.

“As a result, the only thing that could impede success is our will to succeed,” said Dr Lowe.

“We will be working toward seizing a five per cent share of the global nutraceutical industry within the next two years, which translates to a multi-billion-dollar local industry — approximately $726 billion,” he said.

The Bio-Tech R&D Institute brings together Jamaica’s four leading research institutions — the University of the West Indies, University of Technology, Northern Caribbean University and the Scientific Research Council — all of which will receive 2.5 per cent of the total shares of the institute free of cost.

In addition to his other shareholders — Federated Pharmaceutical/Lascelles Limited and the Environmental Health Foundation — Dr Lowe said he has forged a partnership with the largest nutraceutical company in China, which will distribute the formula in that Asian country.

“We expect that gaining even one per cent of the Chinese market will amount to tremendous US dollar value export earnings — perhaps the most rewarding endeavors and investments in our country in recent times,” said Dr Lowe.

A Fearon PhD.